Simplex Trading’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Simplex Trading’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-999	Closed	-$1.77M	–	8374
2018 Q3	$1.77M	Buy	999 +731	+273%	+$12.6K	0.01%	1346
2018 Q2	$369K	Sell	268 -236	-47%	-$2.8K	﹤0.01%	2779
2018 Q1	$21K	Sell	504 -49	-9%	-$270	﹤0.01%	3332
2017 Q4	$23K	Buy	+553	New	+$2.63K	﹤0.01%	3195
2016 Q4	–	Sell	-127	Closed	-$4K	–	6950
2016 Q3	$4K	Buy	+127	New	+$396	﹤0.01%	4581

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Simplex Trading's ECYT Position: Q3 2018 in Review

Simplex Trading sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2018, closing a stake of 16,492 shares — an estimated $283K sold.

Simplex Trading first reported a position in ECYT in Q4 2014 and held it in 12 quarters. The position peaked at $227K in Q2 2018. 139 funds tracked by Wall St. Rank hold ECYT as of Q3 2018.

Simplex Trading reported no remaining Endocyte, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Simplex Trading sold 16,492 Endocyte, Inc. Common Stock shares in Q3 2018, an estimated $283K.
Simplex Trading first reported a position in Endocyte, Inc. Common Stock in Q4 2014 and held it in 12 quarters.
Simplex Trading's Endocyte, Inc. Common Stock position peaked at $227K in Q2 2018.
139 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.